1) Since the CSD works as a single unit, there will be many
CSDs in the injection.
2) To solve the problems of past treatments, where both cancerous and healthy cells were affected by treatment, the CSD will detect cancer cells specifically. First, the CSD will use their EGF receptor finder to locate the EGF receptors.
3) After binding to the EGF receptor, the enzyme sensors will extend into the cancer cell and take an ODC enzyme sample. It will then bring the data back to the ODC-level processors for it to compare the enzyme activity level to the standard enzyme activity levels of a healthy cell.
4) After the ODC levels have been analyzed, confirming that the cell is cancerous, the p53 gene will be released through the nanotube from the p53 storage container. The genes will be carried through this nano-flow tube to the temporary tank where it will stay until the CSD is ready to inject the p53 gene into the cancer cell.
To make sure that the CSD will be accepted by the body a serum that contains antibodies against the patient's blood type will be applied to the outer layer of the CSD, which will already be coated with polymers.
The presence of a large number of EGF receptors will indicate that the cell is cancerous because there are over 100 times the normal number of EGF receptors found on the cell surface.
Research shows that all cancer cells have significantly higher levels of ODC enzyme activity and polyamines than normal cells, and this enzyme is seen as the cancer-causing agent.
The needle will be filled with the p53 gene from the temporary tank. The needle will extend into the cancer cell through the EGF receptor finder and release the p53 gene into the cell. Now that the tumor-suppressing gene is present in the defective cancer cell, the abnormal and uncontrolled growth of the cells will come to a halt.
The tumor will stop growing, and therefore become benign and can be removed surgically or through the outer methods.
EGF Receptor Finder
ODC Enzyme Sensor
p53 Storage Container